Express Scripts has inked a deal with Lewis & Clark Ventures to invest $25m in software developers, device makers and life sciences startups at series A and B stage.
US-based pharmacy benefit manager Express Scripts committed $25m to venture capital firm Lewis & Clark Ventures on Tuesday which will support investments in companies complementing its smart pharmacy strategy.
Lewis & Clark will be responsible for identifying suitable companies, in which it will invest between $3m and $7m at series A and B stage.
The US-based VC firm will consider software developers, device manufacturers and life sciences companies with a focus on healthcare across the financial, enterprise and agriculture sectors.
…
